Navigation Links
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Date:8/21/2007

INDIANAPOLIS, Aug. 21 /PRNewswire-FirstCall/ -- New data suggest that patients with fibromyalgia treated with 60mg or 120mg of Cymbalta(R) (duloxetine HCl) experienced greater reduction in pain severity beginning one week after starting duloxetine than those taking placebo (sugar pill), as measured by the Brief Pain Inventory Average Pain Score (BPI). The study, which included patients with and without depression, also showed greater improvements in patients taking duloxetine than in those taking placebo in scores on the Patient's Global Impression of Improvement questionnaire (PGI- I), which measures how the patient has felt overall since beginning to take the medication. The data were presented today at the 2007 Congress of the International MYOPAIN Society in Washington, D.C.

At three months, patients treated with 60mg per day or 120mg per day of duloxetine showed significantly greater reduction in pain and improvement in PGI-I scores compared with patients taking placebo. At three months, more patients treated with either 60mg or 120mg of duloxetine showed significantly greater reduction in pain as measured by a 30 percent improvement in baseline BPI scores (50.7 percent and 52.1 percent, respectively) compared with patients taking placebo (36 percent).

"Fibromyalgia is a chronic illness, characterized by widespread pain, tenderness and fatigue. It can also affect the patient's overall emotional health and well-being," said I. Jon Russell, M.D., Ph.D., associate professor of medicine at the University of Texas Health Science Center in San Antonio. "Between 34 percent(1) and 62 percent(2) of those living with fibromyalgia will experience depression at some point in their lives. In this study, which included patients with and without depression, duloxetine reduced the pain associated with fibromyalgia."

Fibromyalgia is estimated to affect 2 percent to 4 percent of the U.S. population(3), the majority being women. In addition to chronic pai
'/>"/>

SOURCE Eli Lilly and Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Research and Markets ( ... Report on China,s Sodium Ibandronate Market, 2010-2019" report to ... clinic under the trade name of Bondronat in ... 1996, sodium ibandronate was approved by the FDA to come ... the trade name of Boniva. However, since drug makers later ...
(Date:9/4/2015)... , September 4, 2015 ... today announces that Hutchison MediPharma Limited ("HMP"), its ... in the second proof-of-concept ("POC") trial of fruquintinib ... cancer ("NSCLC") in China . ... succeeded in meeting the primary efficacy endpoint of ...
(Date:9/3/2015)... , Sept. 3, 2015 ... New Guide to that Market, its R&D and Sales Potentials ... assess the future of cancer-treating medicines? Visiongain,s new report gives ... stay ahead. There you discover financial data, R&D trends, opportunities, ... In our analysis you see forecasted sales to 2025 ...
Breaking Medicine Technology:Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7
... Reportlinker.com announces that a new market research ... Chinese Markets for Bladder Cancer Treatment Drugs ... , China,s demand ... a fast pace in the past decade. In ...
... , REDMOND, Wash., Nov. 3 Medical software company ... availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software ... is available for any healthcare professional via download from ... , "There is tremendous unrealized potential in medical ...
Cached Medicine Technology:Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 2Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 3Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 4Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 5Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging 2
(Date:9/4/2015)... ... September 04, 2015 , ... ... is now available at CitiDent. CEREC is a newer method for creating restorations ... time for patients by eliminating the need for multiple appointments, CEREC produces restorations ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way to ... The patent-pending K Med Cups provide a quick and simple way to brew a hot ... flu or cough. As a result, they enhance comfort and health. The invention features a ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at the ... Speakers at the 2015 symposium are doctors and researchers at the top of ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Lalonde Gordon ran ... and followed up with victory in the men’s 400 meters final, with an impressive ... and Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time ...
(Date:9/4/2015)... Texas (PRWEB) , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... he says are prophetic details involving the Pope’s upcoming trip to the United States. , ... details what his role with the Vatican and society is. Yisrayl also provides the meaning ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... months of life, but not fetal growth, is associated with ... to a new study from The Generation R Study Group ... that low birth weight is associated with an increased risk ... fetal and infant growth patterns on this risk had not ...
... , THURSDAY, Jan. 19 (HealthDay News) -- Many ... tract, a problem that can cause serious health problems and ... said their findings show that more needs to be done ... in the esophagus, stomach or first part of the intestine ...
... growing need for family-friendly workplace policies, a new study ... with support from the Rockefeller Foundation, concludes that providing ... outcomes for working families, businesses and the public. ... Work at Rutgers, the State University of New Jersey, ...
... Reporter , THURSDAY, Jan. 19 (HealthDay News) -- The number ... for HIV infection has declined significantly, federal health officials reported ... sexual or drug-related behavior dropped from 13 percent of men ... and 8 percent, respectively, in 2010, according to the U.S. ...
... of autism is now well established, a growing body of ... in this serious developmental disorder affecting nearly one in 100 ... that low birth weight is an important environmental factor contributing ... "Our study of discordant twins -- twin pairs in which ...
... cause of blindness in the Western World. A report from ... today shows the number of new cases of blindness and ... last ten years. The study just published in ... 11,848 new cases of legal blindness. The rate of blindness ...
Cached Medicine News:Health News:Accelerated infant growth increases risk of future asthma symptoms in children 2Health News:Kidney Failure Patients Prone to GI Tract Bleeding 2Health News:Rutgers study finds paid family leave leads to positive economic outcomes 2Health News:Rutgers study finds paid family leave leads to positive economic outcomes 3Health News:More Americans Practicing Safe Sex, CDC Reports 2Health News:More Americans Practicing Safe Sex, CDC Reports 3Health News:Another clue in the mystery of autism 2Health News:Report shows risk of blindness halved over last decade 2
... 48-capillary 3730 DNA Analyzer, upgradeable to 96 ... DNA analysis. , Higher optical sensitivity ... higher-quality data at a lower cost. , ... , Optimized polymers increase your productivity without ...
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
... is an immunochromatography based one step ... qualitative determination of Methamphetamine in human ... 1000 ng/mL. This assay has not ... care,location and is for use by ...
... The RapidAMP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 1000 ng/mL. ... in the point of care,location and ...
Medicine Products: